Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate

Summary

Hypothesis: Treatment with Glatiramer acetate prevents deterioration of gait in multiple sclerosis (MS) patients. During the study patients will undergo a 3 dimensional gait analysis before starting treatment with glatiramer acetate and after 1 year of treatment.

Timeline

Start

2006-05

Primary completion

—

Completion

—

Drugs

Indications